Dr Agarwals Eye Hospital Ltd-$
Dr Agarwals Eye Hospital Ltd-$ (DRAGARWQ) last reported results for the quarter ended Jun 2026, with sales of ₹143 crore and net profit of ₹23 crore. The stock last traded at ₹5,222, a market capitalisation of ₹2,523 crore, on a P/E of 33.1. Over the past 52 weeks the stock has ranged between ₹4,412 and ₹6,392. Figures are as of 6 Oct 2026 and are not real time.
Dr Agarwals Eye Hospital Ltd-$ share price and key metrics
- Current price
- ₹5,222
- Market cap
- ₹2,523 cr
- Stock P/E
- 33.1
- Book value
- ₹717
- ROE
- 24.2%
- ROCE
- 17.2%
- Dividend yield
- 0.13%
- 52w high / low
- 6392/4412
Metrics as of 6 Oct 2026. Not real time.
Track Dr Agarwals Eye Hospital Ltd-$
Cruxal reads every Dr Agarwals Eye Hospital Ltd-$ filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Dr Agarwals Eye Hospital Ltd-$ growth and returns
- 10 Years
- 13%
- 5 Years
- 27%
- 3 Years
- 21%
- TTM
- 20%
- 10 Years
- 35%
- 5 Years
- 118%
- 3 Years
- 22%
- TTM
- 32%
- 10 Years
- 38%
- 5 Years
- 67%
- 3 Years
- 28%
- 1 Year
- 6%
- 10 Years
- 28%
- 5 Years
- 30%
- 3 Years
- 28%
- Last Year
- 24%
Dr Agarwals Eye Hospital Ltd-$ quarterly results
In the quarter ended Jun 2026, sales were ₹143 cr, up 22.2% from ₹117 cr a year earlier. Net profit was ₹23 cr, up 35.3% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 102 | 95 | 100 | 117 | 118 | 116 | 120 | 143 |
| Expenses | 72 | 69 | 68 | 80 | 78 | 82 | 86 | 100 |
| Operating profit | 30 | 26 | 32 | 37 | 40 | 34 | 34 | 43 |
| OPM % | 29% | 27% | 32% | 32% | 34% | 30% | 28% | 30% |
| Other income | 2 | 2 | 0 | 1 | 1 | 3 | 2 | 2 |
| Interest | 4 | 4 | 3 | 4 | 4 | 2 | 2 | 3 |
| Depreciation | 9 | 10 | 10 | 11 | 11 | 12 | 12 | 11 |
| Profit before tax | 19 | 14 | 19 | 23 | 26 | 23 | 21 | 31 |
| Tax % | 26% | 26% | 14% | 26% | 25% | 26% | 24% | 24% |
| Net profit | 14 | 10 | 16 | 17 | 19 | 17 | 16 | 23 |
| EPS (₹) | 30.11 | 22.13 | 34.02 | 36.72 | 39.98 | 35.76 | 33.60 | 48.38 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Dr Agarwals Eye Hospital Ltd-$ annual results
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 149 | 153 | 170 | 176 | 140 | 201 | 268 | 319 | 397 | 471 | 497 |
| Operating profit | 23 | 24 | 30 | 47 | 31 | 59 | 76 | 92 | 120 | 147 | 151 |
| OPM % | 15% | 16% | 18% | 27% | 22% | 29% | 28% | 29% | 30% | 31% | 30% |
| Net profit | 7 | 7 | 12 | 14 | -1 | 24 | 37 | 46 | 55 | 70 | 76 |
| EPS (₹) | 15.62 | 14.43 | 25.36 | 29.11 | -3.06 | 51.28 | 78.55 | 98.64 | 116.28 | 145.05 | 157.72 |
TTM is the trailing twelve months to the most recent quarter.
Dr Agarwals Eye Hospital Ltd-$ balance sheet
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves | 25 | 30 | 41 | 51 | 50 | 73 | 109 | 152 | 205 | 341 |
| Borrowings | 23 | 18 | 24 | 60 | 68 | 193 | 232 | 268 | 333 | 326 |
| Other liabilities | 20 | 28 | 31 | 24 | 33 | 42 | 44 | 71 | 71 | 94 |
| Total liabilities | 72 | 81 | 100 | 141 | 155 | 314 | 390 | 496 | 613 | 766 |
| Fixed assets | 33 | 36 | 55 | 94 | 96 | 214 | 260 | 316 | 393 | 403 |
| CWIP | 1 | 3 | 0 | 0 | -0 | 26 | 62 | 97 | 128 | 197 |
| Investments | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 13 | 89 |
| Other assets | 38 | 42 | 45 | 47 | 60 | 73 | 67 | 83 | 80 | 78 |
| Total assets | 72 | 81 | 100 | 141 | 155 | 314 | 390 | 496 | 613 | 766 |
As reported by the company. Total assets equal total liabilities by construction.
Dr Agarwals Eye Hospital Ltd-$ cash flow
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 20 | 19 | 25 | 39 | 34 | 57 | 70 | 90 | 94 | 145 |
| Cash from investing | -8 | -11 | -25 | -17 | -11 | -46 | -71 | -70 | -133 | -174 |
| Cash from financing | -12 | -8 | 2 | -20 | -8 | -4 | 0 | -14 | 17 | 25 |
| Net cash flow | 0 | -0 | 2 | 2 | 15 | 7 | -1 | 6 | -23 | -4 |
| Free cash flow | 12 | 7 | 0 | 22 | 23 | 10 | -1 | 19 | -9 | 47 |
| CFO / operating profit | 103% | 98% | 111% | 96% | 120% | 112% | 107% | 112% | 95% | 105% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Dr Agarwals Eye Hospital Ltd-$ operating ratios
| Per year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | 29% | 32% | 34% | 30% | 11% | 20% | 19% | 18% | 18% | 17% |
| Debtor days | 16 | 17 | 19 | 14 | 23 | 16 | 14 | 15 | 13 | 14 |
| Inventory days | 123 | 148 | 124 | 132 | 117 | 91 | 73 | 106 | 55 | 51 |
| Days payable | 277 | 353 | 292 | 224 | 401 | 410 | 327 | 345 | 101 | 97 |
| Cash conversion cycle | -138 | -189 | -149 | -78 | -260 | -303 | -240 | -224 | -34 | -31 |
| Working capital days | -25 | -39 | -22 | -34 | -70 | -58 | -50 | -63 | -51 | -55 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Dr Agarwals Eye Hospital Ltd-$ shareholding pattern
Promoters held 72.67% at Jun 2026, up from 71.90% at Jun 2025. FIIs 2.24% and DIIs 2.05%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 71.90% | 71.90% | 71.90% | 71.90% | 72.67% | 72.67% | 72.67% | 72.67% |
| FIIs | 0.83% | 0.84% | 1.33% | 1.49% | 1.74% | 1.82% | 2.20% | 2.24% |
| DIIs | 0.96% | 1.04% | 1.95% | 2.31% | 2.36% | 2.36% | 2.12% | 2.05% |
| Public | 26.32% | 26.22% | 24.82% | 24.29% | 23.22% | 23.15% | 22.99% | 23.03% |
| No. of shareholders | 4,510 | 15,115 | 41,704 | 35,976 | 30,528 | 25,449 | 24,036 | 22,954 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Dr Agarwals Eye Hospital Ltd-$ corporate filings
- Disclosure under Regulation 74(5) of the SEBI (DP) Regulations, 2018, is submitted.Company Updatelow impact
- Regulatory Approval of Scheme of Amalgamation between Dr. Agarwal’s Eye Hospital Limited and Dr. Agarwal’s Health Care LimitedCompany Updatemedium impact
Cruxal's analysis: Dr. Agarwal’s Eye Hospital Limited (AEHL) has received approval from the National Company…
Read the full analysis - The disclosure on closure of trading window is submitted.Insider Trading / SASTlow impact
- Dr. Agarwal's Eye Hospital Limited Announces Successful Conclusion of 32nd AGM and Dividend ApprovalAGM/EGMlow impact
Cruxal's analysis: Dr. Agarwal's Eye Hospital Limited has successfully concluded its 32nd Annual General…
Read the full analysis - Dr. Agarwal’s Eye Hospital Limited Concludes 32nd Annual General Meeting; All Resolutions PassedAGM/EGMlow impact
Cruxal's analysis: Dr. Agarwal’s Eye Hospital Limited has successfully concluded its 32nd Annual General…
Read the full analysis - Dr Agarwals Eye Hospital launches world's first Pinhole Pupilloplasty (PPP) centreCompany Updatelow impact
Cruxal's analysis: Dr Agarwals Eye Hospital has announced the launch of the world's first dedicated centre…
Read the full analysis - Dr Agarwals Eye Hospital Ltd submits newspaper advertisement for 32nd Annual General MeetingCompany Updatelow impact
Cruxal's analysis: The company has filed a copy of the newspaper advertisement regarding its 32nd Annual…
Read the full analysis - Dr. Agarwal's Eye Hospital Limited announces 32nd AGM, final dividend of INR 4.00 per share, and executive remuneration revisionsCorp. Actionlow impact
Cruxal's analysis: Dr. Agarwal's Eye Hospital Limited has scheduled its 32nd Annual General Meeting for…
Read the full analysis - Dr. Agarwal's Eye Hospital Limited submits Annual Report for FY 2025-26Otherslow impact
Cruxal's analysis: Dr. Agarwal's Eye Hospital Limited has filed its Annual Report for the financial year…
Read the full analysis - Invesco Mutual Fund increases stake in Dr. Agarwal's Healthcare Limited to 5.21%Insider Trading / SASTmedium impact
Cruxal's analysis: Invesco Mutual Fund has disclosed an acquisition of shares in Dr. Agarwal's Healthcare…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.